CHRYSALIS COLASANTI: Open Payments
NPI 1528320132 · ELIZABETHTOWN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$436 in 35 payments from 11 companies in 2025. Trend: 2023 $605 · 2024 $1,024 · 2025 $436
Food & beverage: $436
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 19 | $161 |
| Axsome Therapeutics, Inc. | 4 | $72 |
| ABBVIE INC. | 3 | $55 |
| GlaxoSmithKline, LLC. | 2 | $31 |
| Antares Pharma, Inc. | 1 | $21 |
| Lilly USA, LLC | 1 | $19 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
| Inspire Medical Systems, Inc. | 1 | $17 |
| Phathom Pharmaceuticals, Inc. | 1 | $15 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: Wegovy, Auvelity, Rybelsus, UBRELVY, XYOSTED, MOUNJARO, Kerendia, INSPIRE.
Industry payments across KY — which companies pay providers there.
